Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial

Lymphocytic Leukaemia ◽

Phase 3 ◽

Faculty Opinions recommendation of Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727373020.793562618 ◽

2019 ◽

Author(s):

Corrado Girmenia

Keyword(s):

Lymphocytic Leukaemia ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Haematology ◽

10.1016/s2352-3026(17)30168-0 ◽

2017 ◽

Vol 4 (11) ◽

pp. e534-e543 ◽

Cited By ~ 20

Author(s):

Asher A Chanan-Khan ◽

Andrey Zaritskey ◽

Miklos Egyed ◽

Samuel Vokurka ◽

Sergey Semochkin ◽

...

Keyword(s):

Maintenance Therapy ◽

Lymphocytic Leukaemia ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726009690.793538184 ◽

2017 ◽

Author(s):

Varsha Gandhi ◽

Prithviraj Bose

Keyword(s):

Lymphocytic Leukaemia ◽

Small Lymphocytic Lymphoma ◽

Phase 3 ◽

Double Blind ◽

Faculty Opinions recommendation of Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727373020.793538186 ◽

2017 ◽

Author(s):

Varsha Gandhi ◽

Prithviraj Bose

Keyword(s):

Lymphocytic Leukaemia ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial

The Lancet Haematology ◽

10.1016/s2352-3026(17)30019-4 ◽

2017 ◽

Vol 4 (3) ◽

pp. e114-e126 ◽

Cited By ~ 107

Author(s):

Jeffrey A Jones ◽

Tadeusz Robak ◽

Jennifer R Brown ◽

Farrukh T Awan ◽

Xavier Badoux ◽

...

Keyword(s):

Lymphocytic Leukaemia ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

The Lancet Oncology ◽

10.1016/s1470-2045(15)00465-9 ◽

2016 ◽

Vol 17 (2) ◽

pp. 200-211 ◽

Cited By ~ 247

Author(s):

Asher Chanan-Khan ◽

Paula Cramer ◽

Fatih Demirkan ◽

Graeme Fraser ◽

Rodrigo Santucci Silva ◽

...

Keyword(s):

Lymphocytic Leukaemia ◽

Small Lymphocytic Lymphoma ◽

Phase 3 ◽

Double Blind ◽

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

The Lancet ◽

10.1016/s0140-6736(20)30262-2 ◽

2020 ◽

Vol 395 (10232) ◽

pp. 1278-1291 ◽

Cited By ~ 37

Author(s):

Jeff P Sharman ◽

Miklos Egyed ◽

Wojciech Jurczak ◽

Alan Skarbnik ◽

John M Pagel ◽

...

Keyword(s):

Lymphocytic Leukaemia ◽

Phase 3 ◽

Treatment Naïve ◽

Randomised Controlled

Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine

British Journal of Haematology ◽

10.1111/j.1365-2141.2005.05426.x ◽

2005 ◽

Vol 129 (2) ◽

pp. 199-205 ◽

Cited By ~ 46

Author(s):

Dominic Fong ◽

Alexandra Kaiser ◽

Gilbert Spizzo ◽

Guenther Gastl ◽

Alexandar Tzankov

Keyword(s):

Hodgkin's Disease ◽

Lymphocytic Leukaemia ◽

Hodgkin’S Disease ◽

Previously Treated ◽

Disease Variant ◽

Richter’S Syndrome

Response to cladribine in previously treated patients with chronic lymphocytic leukaemia identified by ex vivo assessment of drug sensitivity by DiSC assay

British Journal of Haematology ◽

10.1046/j.1365-2141.1999.01581.x ◽

1999 ◽

Vol 106 (2) ◽

pp. 474-476 ◽

Cited By ~ 9

Author(s):

Andrew G. Bosanquet ◽

J. Adrian Copplestone ◽

Stephen A. N. Johnson ◽

Alastair G. Smith ◽

Sara J. Povey ◽

...

Keyword(s):

Drug Sensitivity ◽

Lymphocytic Leukaemia ◽

Ex Vivo ◽

Previously Treated Patients ◽

Previously Treated ◽

Disc Assay

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients

British Journal of Haematology ◽

10.1046/j.1365-2141.2000.01850.x ◽

2000 ◽

Vol 108 (2) ◽

pp. 357-368 ◽

Cited By ~ 62

Author(s):

Robak ◽

Błoński ◽

Kasznicki ◽

Konopka ◽

Ceglarek ◽

...

Keyword(s):

Multicentre Study ◽

B Cell ◽

Lymphocytic Leukaemia ◽

Cell Chronic Lymphocytic Leukaemia ◽